Immutep Limited (IMMP) Stock Forecast

NASDAQ: IMMPAnalyst ratings, price target and estimates.

IMMP analyst forecast

as of October 17, 2026
Analyst consensus
Buy
4.00 / 5 from 1 analysts
Price target
$30.00
average of analyst targets
Upside to target
+837.5%
from the latest close
Next earnings
—
52-week range
$3.20 – $63.60

IMMP analyst ratings

1 analysts
Strong buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

IMMP price target

Price $3.20Target $30.00
52-week low $3.2052-week high $63.60

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

IMMP earnings per share estimates

Immutep Limited EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current fiscal year (FY2027)−$4.00−$4.00−$4.00−$7.73+48.3%1
Next fiscal year (FY2028)−$5.20−$5.20−$5.20−$4.00−30.0%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

IMMP revenue estimates

Immutep Limited revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current fiscal year (FY2027)$4.0M$4.0M$4.0M−83.5%1
Next fiscal year (FY2028)$3.0M$3.0M$3.0M−25.0%1

IMMP EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

IMMP revenue: reported and forecast

Reported revenueEstimate (average; low–high)

IMMP EPS estimate revisions

Immutep Limited EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current fiscal year (FY2027)−$2.64−$4.40−$4.40−$4.40−$4.00+51.5%1 up · 0 down
Next fiscal year (FY2028)−$2.79−$4.60−$4.60−$4.60−$5.20+86.4%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

IMMP earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; IMMP beat in 10 of 12.

What analysts expect from IMMP

1 analysts cover Immutep; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $30.00, 837.5% above the latest close of $3.20. Analysts expect earnings of −$4.00 per share for FY2027, +48.3% from a year earlier. For FY2028 the average estimate is −$5.20 per share on revenue of $3.0 million. Immutep beat the EPS estimate in 10 of the last 12 quarters.

Related: IMMP income statement, IMMP key metrics, IMMP chart. See the IMMP stock overview for the latest quote and news.

IMMP forecast FAQ

What is Immutep's price target?

The average analyst price target for Immutep is $30.00, 837.5% above the latest close of $3.20.

Is Immutep a buy, hold or sell?

Of 1 analysts covering Immutep, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Immutep's EPS forecast?

Analysts forecast −$4.00 per share for FY2027 (range −$4.00 to −$4.00); for FY2028 the estimate is −$5.20.

What is Immutep's revenue forecast?

The average revenue estimate for FY2027 is $4.0 million, growth of −83.5%; for FY2028 it is $3.0 million.

Does Immutep usually beat earnings estimates?

Immutep reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Biotechnology: forecast